Your search returned 10 results.

Results
	1.	Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia. [electronic resource] by Aronson, Ronnie Umpierrez, Guillermo Stager, William Kovatchev, Boris Producer: 20200203 In: Diabetes, obesity & metabolism vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Efficacy of iGlarLixi, a fixed-ratio combination of insulin glargine and lixisenatide, in patients with type 2 diabetes stratified as at high or low risk according to HEDIS measurements. [electronic resource] by Sugimoto, Danny H Dex, Terry Stager, William Aroda, Vanita R Producer: 20190415 In: Diabetes, obesity & metabolism vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Achieving postprandial glucose control with lixisenatide improves glycemic control in patients with type 2 diabetes on basal insulin: a post-hoc analysis of pooled data. [electronic resource] by Davidson, Jaime A Stager, William Paranjape, Sachin Berria, Rachele Leiter, Lawrence A Publication details: Clinical diabetes and endocrinology 2020 In: Clinical diabetes and endocrinology vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Post hoc efficacy and safety analysis of insulin glargine/lixisenatide fixed- ratio combination in North American patients compared with the rest of world. [electronic resource] by Dailey, George Bajaj, Harpreet S Dex, Terry Groleau, Melanie Stager, William Vinik, Aaron Producer: 20200427 In: BMJ open diabetes research & care vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme. [electronic resource] by Broglio, Fabio Mannucci, Edoardo Napoli, Raffaele Nicolucci, Antonio Purrello, Francesco Nikonova, Elena Stager, William Trevisan, Roberto Producer: 20171101 In: Diabetes, obesity & metabolism vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment. [electronic resource] by Hanefeld, Markolf Arteaga, Juan M Leiter, Lawrence A Marchesini, Giulio Nikonova, Elena Shestakova, Marina Stager, William Gómez-Huelgas, Ricardo Producer: 20180612 In: Diabetes, obesity & metabolism vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes. [electronic resource] by Handelsman, Yehuda Chovanes, Christina Dex, Terry Giorgino, Francesco Skolnik, Neil Souhami, Elisabeth Stager, William Niemoeller, Elisabeth Frias, Juan Pablo Producer: 20200702 In: Journal of diabetes and its complications vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus: A Post Hoc Analysis. [electronic resource] by Ahrén, Bo Galstyan, Gagik Gautier, Jean-Francois Giorgino, Francesco Gomez-Peralta, Fernando Krebs, Michael Nikonova, Elena Stager, William Vargas-Uricoechea, Hernando Producer: 20160908 In: Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents. [electronic resource] by Davies, Melanie J Leiter, Lawrence A Guerci, Bruno Grunberger, George Ampudia-Blasco, F Javier Yu, Christine Stager, William Niemoeller, Elisabeth Souhami, Elisabeth Rosenstock, Julio Producer: 20180720 In: Diabetes, obesity & metabolism vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. [electronic resource] by Wysham, Carol Bonadonna, Riccardo C Aroda, Vanita R Puig Domingo, Manuel Kapitza, Christoph Stager, William Yu, Christine Niemoeller, Elisabeth Souhami, Elisabeth Bergenstal, Richard M Producer: 20180712 In: Diabetes, obesity & metabolism vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)